CD44 and cancer: The analysis of trajectories highlighted the stability of the modeled HABD and TMD, as well as the conformational flexibility and structural dynamics of the unstructured regions that may allow CD44 to perform its unconventional activity, as has been observed in cancer [43,44,45] and immune response [16,46,47].